Expression of cell cycle regulating proteins in an unusual transformation of mantle cell lymphoma

Leukemia and Lymphoma

Volumn 36, Issue 1-2, 1999, Pages 129-137

  Tamaru, Jun Ichi ^a,b   Kawana, Hidetada ^b   Takahashi, Yoko ^b   Takahashi, Naoki ^b   Isobe, Kouichi ^b   Hirai, Aizan ^c   Saito, Yasushi ^c   Harigaya, Kenichi ^b   Itoyama, Shinji ^a   Mikata, Atsuo ^a,b  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b School of Medicine   (Japan)

^c CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cyclin E; IgH somatic mutation; Mantle cell lymphoma; p27(Kip1); p53; Tumor transformation

Indexed keywords

CD23 ANTIGEN; CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN D1; CYCLIN E; IMMUNOGLOBULIN D; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN M; PROTEIN P27; PROTEIN P53;

ADULT; ARTICLE; BIOPSY; CASE REPORT; CELL CYCLE; DISEASE COURSE; GENE OVEREXPRESSION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MALE; MANTLE CELL LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELAPSE; TUMOR DIFFERENTIATION;

EID: 0033452862     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909145956     Document Type: Article

References (62)

1. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B., Gatter, K., Grogan, T.M., Isaacson, P.G., Knowles, D.M., Mason, D.Y. Muller-Hermelink, H.K., Pileri, S., Piris, M.A., Ralfkiaer, E., Warnke, R. (1994). A Revised European-American Classification of Lymphoid Neoplasms: A proposal from the International Lymphoma Study Group. Blood, 84, 1361-1392.
2. Weisenburger, D.D., Kim, H., Ruppaport, H. Mantle zone lymphoma: A follicular variant of intermediate lymphocytic lymphoma(1982). Cancer, 49, 1429-1438.
3. Hummel, M., Tamaru, J., Kalvelage, B., Stein, H. Mantle cell (previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiological cells of the follicle mantle(1994). Blood, 84, 403-407.
4. Stein, H., Gerdes, J., Mason, D.Y., The normal and malignant germinal centre (1982). Clinics in Haematology, 11: 53-591.
5. Stein, H., Lennert, K., Feller, A.C., Mason, D.Y., Immunohistological analysis of human lymphoma: Correlation of histological and immunological categories(1984). Adv. Cancer Res., 42, 67-147.
6. Banks, P.M., Chan, J., Clearly, M.L., Delsol, G., De Wolf-Peeters, C., Gatter, K., Grogan, T.M., Harris, N.L., Isaacson, P.G., Jaffe, E.S., Mason, D.Y., Pileri, S., Ralfkiaer, E., Stein, H., Warnke, R. Mantle cell lymphoma: A proposal for unification of morphologic, immunologic, and molecular data(1993). Am. J. Surg. Pathol, 17, 639-641.
7. Norton, A.J., Mathews, J., Pappa, V., Shamash, J., Love, S., Rohatiner, A.Z.S., Lister, T.A. Mantle cell lymphoma: Natural history defined in a serially hiopsied population over a 20-year period(1995). Ann. Oncol. 6, 249-256.
8. Weisenburger, D.D. and Armitage, J.O. Mantle cell lymphoma - An entity comes of age(1996). Blood, 87, 4483-4494.
9. Lennert, K., Feller, A.C. (1992). Hislopathology of non-Hodgkin's lymphomas. 2nd ed. Berlin: Springer-Verlag.
10. Lardelli, P., Bookman, M.A., Sundeen, J., Longo, D.L., Jaffe, E.S., Lymphocytic lymphoma of intermediate differentiation: Morphologic and immunophenotypic spectrum and clinical correlations(1990). Am. J Surg. Pathol, 14, 752-763.
11. Lennert, K., Stein, H., Kaiserling, E., Cytologic and functional criteria for the classification of malignant lymphomata(1975). Br. J. Cancer, 31, 29-43.
12. Plank, L., Hansmann, M-L., Lennert, K., Centrocytic lymphomas(1993). Am. J. Surg. Pathol, 17, 638-639.
13. Hui, P.K., Feller, A.C., Lennert, K., High-grade non-Hodgkin's lymphoma of B-cell type. I(1988). Histopathology, 12, 127-143.
14. Ott, M.M., Ott, G., Kuse, R., Porowski, P., Gunzer, U., Feller, A.C., Muller-Hermelink, H.K., The anaplastic variant of centrocytic lymphoma is marked by frequent rearrangements of the bcl-1 gene and high proliferative indices(1994). Histopathology, 24, 329-334.
15. k genes with no or little somatic mutations throughout life(1993). Eur. J. Immunol, 23, 3272-3277.
16. Kueppers, R., Zhao, M., Hansmann, M-L., Rajewsky, K., Tracing B cell development in human germinal centres by molecular analysis of single cell picked from histologic sections(1993). EMBO J, 12, 4955-4967.
17. Pinyol, M., Hernandez, L., Cazorla, M., Balbin, M., Jares, P., Fernandez, P.L., Montserrat, E., Cardesa, A., Lopez-Otin, C., Campo, E., Deletions and loss of expression of p16INK4a and p21 Waf1 genes are associated with aggressive variants of mantle cell lymphomas(1997). Blood, 89, 272-280.
18. Sherr, C.J., Cancer cell cycles(1996). Science, 274, 1672-1677.
19. Hirai, A., Nakamura, S., Noguchi, Y., Yasuda, T., Kitagawa, M., Tatsuno, I., Oeda, T., Tahara, K., Terano, T., Narumiya, S., Kohn, L.D., Saito, Y., Geranylgeranylated Rho small GTPase(s) are essential for the degradation of p27Kip1 and facilitate the progression from G1 to S phase in growth-stimulated rat FRTL-5 cells(1997). J. Biol. Chem, 272, 13-16.
20. Tamaru, J., Hummel, M., Zemlin, M., Kalvelage, B., Stein, H., Hodgkin's disease with a B cell phenotype often shows a VDJ rearrangement and somatic mutations in the VH genes(1994). Blood, 84, 708-715.
21. Stein, H., Dallenbach, F. (1992). Diffuse large cell lymphomas of B and T cell type. In Neoplastic Hematopathology. Edited by Knowles, D.M. pp. 657-714. Baltimore, Williams & Wilkins.
22. Nakamine, H., Bagin, R.G., Vose, J.M., Bast, M.A., Bierman, P.J., Armitage, J.O., Weisenburger, D.D., Prognostic significance of clinical and pathologic feartures in diffuse large B-cell lymphoma(1993). Cancer, 71, 3130-3137.
23. Farrugia, M.M., Duan, L.J., Reis, M.D., Ngan, B.Y., Berinstein, N.L., Alterations of the p53 tumor suppressor gene in diffuse large cell lymphomas with translations of the c-myc and bcl-2 proto-oncogenes(1994). Blood, 83, 191-198.
24. Matolcsy, A., Chadburn, A., Knowles, D.M., De novo CD5-positive and Richter' syndrom-associated diffuse large B cell lymphomas are genotypically distinct(1995). Am. J. Pathol, 147, 207-216.
25. Hubbard, S.M., Chabner, B.A., De, Vita, V.T. Jr, Simon, R., Berard, C.W., Jones, R.B., Garvin, AJ., Canellos, G.P., Osborne, C.K., Young, R.C., Histologic progression in non-Hodgkin' s lymphoma(1982). Blood, 59, 258-264.
26. Chan, J.K.C., NG, C.S., Isaacson, P.G., Relationship between high-grade lymphoma and low-grade B-cell mucosa-associated lymphoid tissue lymphoma (MALToma) of the stomach(1990). Am. J. Pathol, 136, 1153-1164.
27. Foon, K.A., Thiruvengadam, R., Saven, A., Bernstein, Z.P., Gale, R.P., Genetic relatedness of lymphoid malignancies: transformation of chronic lymphocytic leukemia as a model (1993). Ann. Intern. Med. 119, 63-73.
28. Bateman, A.C., Wright, D.H., Epitheliotropism in high-grade lymphomas of mucosa-associated lymphoid tissue(1993). Histopathology, 23, 409-415.
29. Soslow, R.A., Zukerberg, L.R., Harris, N.L., Warnke, R.A., BCL-1 (PRAD-1/Cyclin D-1) overexpression distinguishes the blastoid variant of mantle cell lymphoma from B-lineage lymphoblastic lymphoma(1997). Mod Pathol, 10, 810-817.
30. Hollema, H. and Poppema, S., Immunophenotypes of malignant lymphoma centroblastic-centrocytic and malignant lymphoma centrocytic: an immunohistologic study indicating a derivation from different stages of B cell differentiation(1988). Hum Pathol, 19, 1053-59.
31. Swerdlow, S.H., Habeshaw, J.A., Murray, L.J., Dhaliwal, H.S., Lister, T.A., Stansfeld, A.G., Centrocytic lymphoma: A distinct clinicopathologic and immunologic entity. A multi-parameter study of 18 cases at diagnosis and relapse(1983). Am. J. Pathol, 113, 181-197.
32. Zoldan, M.C., Inghirami, G., Masuda, Y., Vandekerckhove, F., Raphael, B., Amorosi, E., Hymes, K., Frizzera, G., Large-cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome(1996). Br J Haematol, 93, 475-486.
33. Hernandez, L., Fest, T., Cazorla, M., Teruya-Feldstein, J., Bosch, F., Peinado, M.A., Piris, M.A., Montserrat, E., Cardesa, A., Jaffe, E.S., Campo, E., Raffeld, M., p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas(1996). Blood, 87, 3351-3359.
34. Zelenetz, A.D., Chen, T.T., Levy, R., Histological transformation of follicular lymphoma to diffuse large lymphoma represents tumor progression by a single malignant B cell(1991). J. Exp. Med, 173, 197-207.
35. Stiernholm, N., Kuzniar, B., Berinstein, N.L., Absence of immunoglobulin variable region hypermutation in a large cell lymphoma after in vivo and in vitro propagation(1992). Blood, 80, 738-43.
36. Kueppers, R., Gause, A., Rajewsky, K., B cells of chronic lymphatic leukemia express V genes in unmutated form(1991). Leuk Res, 15, 487-496.
37. Levy, R., Levy, S., Cleary, M.L., Carroll, W., Kon, S., Bird, J., Sklar, J., Somatic mutations in human B-cell tumors(1989). Immunol. Rev, 96, 43-58.
38. Bird, J., Galili, N., Link, M., Stites, D., Sklar, J., Continuing rearrangement but absence of somatic hypermutation in immunoglobulin genes of human B cell precursor leukemia (1988). J. Exp. Med, 168, 229-245.
39. Bakkus, M.H.C., Heirman, C., Van Riet, I., Van Camp, B., Thielemans, K., Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation(1992). Blood, 80, 2326-2335.
40. Tamaru, J., Hummel, M., Marafioti, T., Kalvelage, B., Leoncini, L., Minacci, C., Tosi, P., Wright, D., Stein, H., Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations(1995). Am. J. Pathol, 147, 1398-1407.
41. KIP1 expression is inversely proportianal to the proliferative index(1997). Am. J. Pathol, 151, 151-160.
42. Erlanson, M., Portin, C., Linderholm, B., Lindh, J., Roos, G., Landberg, G., Expression of cyclin E and the cyclin-dependent kinase Inhibitor p27 in malignant lymphomas - prognostic implications (1998). Blood, 92, 770-777.
43. Gaidano, G., Ballerini, P., Gong, J.Z., Inghirami, G., Neri, A., Newcomb, E.W., Magrath, I.T., Knowles, D.M., Dalla-Favera, R., p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia (1991). Proc. Natl. Acad. Sci. USA, 88, 5413-17.
44. Sander, C.A., Yano, T., Clark, H.M., Harris, C., Longo, D.L., Jaffe, E.S., Rarfeld, M., p53 mutation is associated with progression in follicular lymphomas (1993). Blood, 82, 1994-2004.
45. Lo Coco, F., Gaidano, G., Louie, D.C., Offit, K., Chaganti, R.S., Dalla-Favera, R., p53 mutations are associated with histologic transformation of follicular lymphoma (1993). Blood, 82, 2289-2295.
46. Mori, N., Wada, M., Yokota, J., Terada, M., Okada, M., Teramura, M., Masuda, M., Hoshino, S., Motoji, T., Oshimi, K., Mizokuchi, H., Mutations of the p53 tumour suppressor gene in haematologic neoplasms (1992). Br. J. Haematol, 81, 235-40.
47. Adamson, DJ., Dawson, A.A., Bennett, B., King, DJ., Haites, N.E., p53 mutation in the myelodysplastic syndromes (1995). Br. J. Haematol, 89, 61-66.
48. Nishimura, S., Asou, N., Suzushima, H., Okubo, T., Fujimoto, T., Osato, M., Yamasaki, H., Lisha, L, Takatsuki, K., p53 gene mutation and loss of heterozygosity are associated with increased risk of disease progression in adult T cell leukemia (1995). Leukemia, 9, 598-604.
49. Hirama, T., Koeffler, H.P., Role of the cyclin-dependent kinuse inhibitors in the development of cancer (1995). Blood, 86, 841-854.
50. Louie, D.C., Offit, K., Jaslow, R., Parsa, N.Z., Murty, V.V.V.S., Schuluger, A., Chaganti, R.S.K., p53 over expression as a marker of poor prognosis in mantle cell lymphomas with the t(11; 14)(q13; q32)(1995). Blood, 86, 2892-2899.
51. Greiner, T.C., Moynihan, M.J., Chan, W.C., Lylle, D.M., Pederson, A., Anderson, J.R., Weisenburger, D.D., p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis (1996). Blood, 87, 4302-4310.
52. Scuderi, R., Palucka, K.A., Pokrovskaja, K., Bjoerkholm, M., Wiman, K.G., Pisa, P., Cyclin E overexpression in relapsed adult acute lymphoblastic leukemias of B-cell lineage (1996). Blood, 87, 3360-3367.
53. Porter, P.L., Malone, K.E., Heagerty, P.J., Alexander, G.M., Gatti, L.A., Firpo, E.J., Daling, J.R., Roberts, JM., Expression of cell-cycle regulators p27KIP1 and cyclinE, alone and in combination, correlate with survival in young breast cancer patients (1997). Nature Medicine, 3, 222-225.
54. Catzavelos, C., Bhattacharya, N., Ung, Y.C., Wilson, J.A., Roncari, L., Sandhu, C., Shaw, P., Yeger, H., Morava-Protzner, I., Kapusta, L., Franssen, E., Pritchard, K., Slingerland, J.M., Decreased levels of the cell-cycle inhibitor p27KIP1 protein: Prognostic implications in primary breast cancer (1997). Nature Medicine, 3, 227-230.
55. Loda, M., Cukor, B., Tam, S.W., Lavin, P., Fiorentino, M., Draetta, G.F., Jessup, J.M., Pagaro, M., Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas (1997). Nature Medicine, 3, 231-34.
56. Kawana, H., Tamaru, J., Tanaka, T., Hirai, A., Saito, Y., Kitagawa, M., Mikata, A., Kenichi, H., Kuriyama, T., Role of p27Kip1 and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer (1948). Am. J. Pathol, 153, 505-513.
57. Morosetti, R., Kawamata, N., Gombart, A.F., Miller, C.W., Hatta, Y., Hirama, T., Said, J.W., Tomonaga, M., Koeffler, H.P., Alterations of p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma (1995). Blood, 86, 1924-1930.
58. Hunter, T., Pines, J., Cyclins and cancer. II: Cydin D and CDK inhibitors come of age (1994). Cell, 79, 573-582.
59. Polyak, K., Lee, M.H., Erdjument-Bromage, H., Koff, A., Roberts, J.M., Tempst, P., Massague, J., Cloning of p27/Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals (1994). Cell, 78, 59-66.
60. Toyoshima, H., Hunter, T., p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21 (1994). Cell, 78, 67-74.
61. Kato, J., Matsuoka, M., Polyak, K., Massague, J., Sherr, C.J., Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27KIP1) of cyclin dependent kinase 4 activation (1994). Cell, 79, 487-96.
62. Grosso, L.E., Kelley, D., bcl-1 translocations are frequent in the paraimmunoblastic variant of small lymphocytic lymphoma (1998). Mod. Pathol, 11, 6-10.